Home Doctor AI Raises ¥10M in Series Pre-A Financing

Doctor AI Raises ¥10M in Series Pre-A Financing

CST Updated Feb 18, 2021 16:33

(VCBeat) Feb. 4, 2021 -- Beijing Yisheng Intelligent Technology Co., Ltd. ("Doctor AI") recently secured 10 million yuan in a Series Pre-A funding round, led by Plum Ventures, with participation from the existing investor Marathon Venture Partners. The funds raised in this round will be mainly used for the upgrading and marketing of the AI-based product for medical record quality control of Doctor AI.


In every first-class hospital at grade 3 where Doctor AI's products are installed, the AI system reaches every clinician with high frequency, providing quality controls of tens of thousands of inpatient and outpatient medical records every day, and feedbacks thousands of medical records with serious defects. Under the DRG payment system, the company's AI-powered medical record quality control system can prevent hospitals from economic losses of tens of millions or even hundreds of millions of yuan every year.


In the past three years, Doctor AI has completed the development of the "quality-control level" NLP engine. In 2020, the company successfully created a benchmark hospital for its products, and make a breakthrough in commercialization.


With excellent products and remarkable application in the hospitals, Doctor AI has become AstraZeneca's sole partner in DRG and medical record quality control in 2020. The two companies have worked closely in product commercialization and promotion.


>>>>

About Plum Ventures


Plum Ventures is a venture capital company that aims to encourage young people to become entrepreneurs. It specializes ins providing seed and early-stage investments in the technology, new media, and telecommunications industry. The firm was founded in May 2014 and is based in Changzhou, China.


>>>>

About Marathon Venture Partners ("MVP")


Founded in 2016, MVP is a leading early-stage venture capital firm focused in healthcare with offices in Beijing, Shanghai, Suzhou and Hong Kong. MVP currently manages both US Dollar and RMB funds. MVP backs outstanding entrepreneurs in China's healthcare technology industries at the beginning of their entrepreneurial journey.